Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
| calculated difference between measured cations and anions | The chemistry report lists an anion gap of 19 mmol/L. | Objective | Electrolytes, acid-base and metabolic testing | |
anthropometry | measurement of body size and proportions | Today's anthropometry includes weight, length, and head circumference. | Objective | Infants, growth and feeding observations |
antibody avidity | measure of the overall binding strength of an antibody population | Antibody avidity was reported with the assay-specific interpretation. | Objective | Molecular testing, serology and culture findings |
antibody titer | dilution-based measure of antibodies in a specimen | The convalescent antibody titer is reported with the initial result. | Objective | Microbiology and specimen interpretation |
antithrombin activity | functional measure of the plasma inhibitor antithrombin | Antithrombin activity was interpreted with the timing of the acute thrombosis. | Objective | Coagulation, antibodies and hemostasis studies |
arterial blood gas | blood gas measured from an arterial specimen | The arterial blood gas was obtained on the recorded oxygen setting. | Objective | Electrolytes, acid-base and metabolic testing |
arterial duplex ultrasound | ultrasound imaging combined with blood-flow measurements in arteries | Request arterial duplex ultrasound of the symptomatic limb. | Plan | Perioperative, diagnostic and follow-up actions |
| apparent finding produced by the measurement process | Motion artifact limits evaluation of the lung bases. | Objective | Laboratory, imaging and test descriptors | |
assay-specific target | target defined using a particular measurement method | The assay-specific target was checked before comparing results reported by two laboratories. | Assessment | Medication response, exposure and reconciliation |
assay confirmation | additional laboratory verification of the measured result | Contact the laboratory to request assay confirmation of the unexpected value. | Plan | Drug levels - verification and documentation |
assay cross-reactivity | measurement response to substances other than the intended analyte | The laboratory was asked whether assay cross-reactivity might affect the immunoassay result. | Assessment | Drug concentrations, exposure and assay interpretation |
assay imprecision | random variation on repeated measurement of the same material | The difference between near-identical repeat results may reflect assay imprecision. | Assessment | Drug concentrations, exposure and assay interpretation |
assay interference | another substance or condition alters the measurement | The laboratory appended a comment about possible assay interference. | Objective | Drug levels - analyte, specimen and reporting |
| units attached to the measured laboratory value | Verify the assay units before comparing the outside result. | Plan | Drug levels - verification and documentation | |
assay variability | variation attributable to measurement methods or performance | The small difference is being reviewed in light of assay variability. | Assessment | Medication exposure, response and adverse-effect reasoning |
audiometry | measurement of hearing thresholds | Arrange formal audiometry for the reported hearing change. | Plan | Diagnostic procedures and specimen handling |
azotemia | increase in nitrogenous waste measured in blood | The rise in urea nitrogen and creatinine documents azotemia. | Objective | Blood count, chemistry and urine findings |
baseline comparison | comparison with the patient's own prior measure | Use the last stable outpatient result for baseline comparison. | Plan | Monitoring actions, escalation and result communication |
baseline level | concentration measured before a defined change | The baseline level predates the formulation switch. | Objective | Drug levels - collection and dose timing |
Berg Balance Scale | multi-item measure of balance during functional tasks | Berg Balance Scale was completed with the total and difficult items recorded. | Objective | Gait, transfers and functional measurements |
beta-D-glucan | fungal cell-wall component measured by a nonspecies-specific assay | Beta-D-glucan was reported with the laboratory cutoff and exposure history. | Objective | Molecular testing, serology and culture findings |
beta-hydroxybutyrate | ketone body measured in blood | Serum beta-hydroxybutyrate is elevated on the paired specimen. | Objective | Electrolytes, acid-base and metabolic testing |
Bethesda titer | measure of the activity of a specific clotting factor inhibitor | The Bethesda titer was supplied with the method and units. | Objective | Coagulation, antibodies and hemostasis studies |
between-method variability | differences attributable to the measurement methods used | The results were reviewed for between-method variability after the assay changed. | Assessment | Diagnostic reasoning and strength of evidence |
bicarbonate | major blood buffer measured or calculated on laboratory studies | Serum bicarbonate was 18 mmol/L. | Objective | Electrolytes, acid-base and metabolic testing |